1 / 22

Optimising the brain-stem dead donor

Optimising the brain-stem dead donor. Dr Gerlinde Mandersloot National Clinical Lead - Donor Optimisation. Dr Gerlinde Mandersloot 20 th April 2012. 1. Organ Donation Past, Present and Future . Challenges. Physiological consequences of BSD. Organ Donation Past, Present and Future .

yanka
Download Presentation

Optimising the brain-stem dead donor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Optimising the brain-stem dead donor Dr Gerlinde Mandersloot National Clinical Lead - Donor Optimisation Dr Gerlinde Mandersloot 20th April 2012 1 Organ Donation Past, Present and Future

  2. Challenges • Physiological consequences of BSD Organ Donation Past, Present and Future

  3. ‘Collateral damage’ • Hormonal • Diabetes insipidus • Hypovolaemia • Hypernatraemia • T3 / T4 reduces • ACTH • Blood glucose • Hypothermia 5 Organ Donation Past, Present and Future

  4. Incidence of organ involvement • Hypotension 81% • Diabetes insipidus65% • DIC 28% • Cardiac dysrhythmias 25% • Pulmonary oedema 18% • Metabolic acidosis 11% J Heart Lung Transplantation 2004 (suppl) 6 Organ Donation Past, Present and Future

  5. Challenges • Physiological consequences of BSD • Stabilisation and brainstem death testing Organ Donation Past, Present and Future

  6. Stabilisation of a patient to facilitate neurological examination • Difficulties in defining futility, especially in survivors • Replace by concept of ‘Best Interests’ • Not only medical factors taken into account • Stabilisation of patient prior to BSD testing • Brainstem death testing is part of a neurological examination of the patient • Clinical in the majority of cases • Ancillary tests where required • Active management may be necessary in order to examine accurately • Continued care after BSD to explore possibility of donation • Integral part of every End of Life Care Plan

  7. Challenges • Physiological consequences of BSD • Stabilisationand brainstem death testing • Consistent donor optimisation • 65% of units have 2 or fewer donor per year • 23% of donors are from these units • Only 4% units have 10 or more donor per year, 28% of the total donor population Organ Donation Past, Present and Future

  8. Make sure they aren’t hypovolaemic, please Decent perfusion, good gases and BP, it can only get worse Give me a CVP of 6-10 Just get on with it!! Lots of fluid please -better function earlier Fluid overload is a problem for us-if we get goals with less that’s good I’d like 10-12 Too much-less than 6

  9. Evidence • Totsuka Transplant Proc. 2000; 32;322-326 • High sodium in liver donor doubles graft loss • Rosendale Transplantation 2003. 75 (4): 482-487 • Protocol increased organs per donor 3.1 to 3.8. Increased probability of transplant • Snell J Heart Lung Transplant 2008;27:662-7 • 54% of Australian lung donations used for transplant vs. 13% in UK 11 Organ Donation Past, Present and Future

  10. Organ Donation Past, Present and Future

  11. 13 Organ Donation Past, Present and Future

  12. Unifying practice across the UK • Optimisation tool • Non-controversial (or not too controversial) • Not too complicated • One side of an A4 ? • Buy-in from retrieval / transplant community • Easy to audit • Extended Care Bundle with two components • Prescription: medical staff • Implementation • Critical care nurses • SN-ODs • ‘Scouts’ • Monitoring implementation Organ Donation Past, Present and Future

  13. Organ Donation Past, Present and Future

  14. Organ Donation Past, Present and Future

  15. Priorities, if not already addressed • Assess fluid status and correct hypovolaemia with fluid boluses as required • Perform lung recruitment manoeuvre(s) as at risk of atelectasis following apnoea tests • Identify, arrest and reverse effects of Diabetes insipidus • Introduce vasopressin infusion: reduces Norepinephrine requirements and treats DI • Methylprednisolone, 15 mg/kg to max of 1g, as soon as possible Organ Donation Past, Present and Future

  16. Hormonal treatment • Vasopressin • Reduction in other vaso-active drugs • Dose: 1 – 4 units/h (can start with boluses of 1 unit at a time) • Liothyronine (T3) • No clear evidence for use • May add haemodynamic stability in very unstable donor • Dose: 3 units/h, sometimes bolus of 4 units asked for by retrieval team • Methylprednisolone in all cases • Dose: 15 mg/kg up to 1g • Insulin • At least 1 unit/h (occasionally may need to add glucose infusion) • ‘Tight’ glycaemic control (4 - 10 mmol/l) 18 Organ Donation Past, Present and Future

  17. Organ Donation Past, Present and Future

  18. Monitoring optimisation • Implementation: use of care bundle • Adherence easy to monitor • Audit first 5 priorities • Results of optimisation evaluated • Number of organs retrieved • Increase in cardiothoracic organs retrieved • Quality of organs: graft function in recipients • Delayed graft function • Quality: biomarkers • Duration of graft function: long term project Organ Donation Past, Present and Future

More Related